Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
CA 2404358 A1 · Owner: Akzo Nobel N.V. · Inventors: Nickolson, Victor Johannes
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a combination comprising paracetamol or a nonsteroidal anti-inflammatory drug (NSAID) or a pharmaceutically acceptable , salt or solvate thereof and another drug, in which combination the other drug is mirtazapine, or a pharmaceutically acceptable salt or solvate thereof optionally in association with one or more pharmaceutically acceptable carriers, whereby paracetamol or an NSAID and mirtazapine are present in the combination in such amounts that the effect of the composition is more favourable than the added effects of the amounts of each drug separately. This combination can be used in the treatment of headache whereby the invention , also provides for a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 4, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 4, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 4, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.